CD68 and cancer: High numbers of CD68+ TAMs were associated with an advanced pT category and high-grade cancer [24], acting as an additional independent factor (CD68/CD3 ratio > 1) with a more than 7-fold higher risk of cancer-specific death on multivariate analysis [25].